Quest Laboratories Ratios

Quest Laboratories Ltd Ratios

The Quest Laboratories Ltd Ratios page provides a complete fundamental analysis of Quest Laboratories Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Quest Laboratories Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Quest Laboratories Ltd (NSE: QUESTLAB, BSE: 92906) is currently trading at ₹137.05, with a market capitalization of ₹2.36B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Quest Laboratories Ltd remains a key stock for fundamental analysis using Quest Laboratories Ltd Ratios.

Quest Laboratories Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Quest Laboratories Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Quest Laboratories Ltd Ratios.

Historically, the Quest Laboratories Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The decline in Quest Laboratories Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Quest Laboratories Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Quest Laboratories Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Quest Laboratories Ltd P/S ratio currently stands at 0, an important part of Quest Laboratories Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

A stable or declining Quest Laboratories Ltd P/S ratio indicates cautious market sentiment.

Quest Laboratories Ltd Price to Cash Flow Ratio (P/CF)

The Quest Laboratories Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Quest Laboratories Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The declining Quest Laboratories Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Quest Laboratories Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Quest Laboratories Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Quest Laboratories Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Quest Laboratories Ltd EV/EBITDA ratio is currently 0, a key metric in Quest Laboratories Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Stable Quest Laboratories Ltd EV/EBITDA indicates balanced valuation.

Quest Laboratories Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Quest Laboratories Ltd D/E ratio is currently 0.37, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.37
• 2023: 0.18
• 2022: 0.27
• 2021: 0.31

Quest Laboratories Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Quest Laboratories Ltd ROE currently stands at 24.57%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 24.57
• 2023: 46.13
• 2022: 40.21
• 2021: 51.69

Quest Laboratories Ltd demonstrates strong profitability and efficient capital utilization.

Quest Laboratories Ltd Ratios Analysis Summary

The Quest Laboratories Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Quest Laboratories Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Quest Laboratories Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.